Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: Differences in MDA-MB-231 and MCF-7 breast cancer cell lines

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Gest, Caroline ^a   Joimel, Ulrich ^a,e   Huang, Limin ^a,b   Pritchard, Linda Louise ^c   Petit, Alexandre ^a   Dulong, Charlène ^a   Buquet, Catherine ^a   Hu, Chao Quan ^b   Mirshahi, Pezhman ^d   Laurent, Marc ^a   Fauvel Lafève, Françoise ^b   Cazin, Lionel ^a   Vannier, Jean Pierre ^a   Lu, He ^b   Soria, Jeannette ^d,e   Li, Hong ^a   Varin, Rémi ^a   Soria, Claudine ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e HÔTEL DIEU   (France)

Author keywords

Breast cancer; Cancer aggressiveness; ERK; NF B; Rac3 GTPases

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN RAC3; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL STRAIN MCF 7; CYTOKINE RELEASE; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR BIOLOGY; PROTEIN DEPLETION; PROTEIN EXPRESSION;

APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL SHAPE; CELL SURVIVAL; COLLAGEN; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; NEOPLASM INVASIVENESS; NF-KAPPA B; RAC GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873262179     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-63     Document Type: Article

References (48)

1. Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999, 81(5):682-687. 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B, 10328216.
2. Bellizzi A, Mangia A, Chiriatti A, Petroni S, Quaranta M, Schittulli F, Malfettone A, Cardone RA, Paradiso A, Reshkin SJ. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int J Mol Med 2008, 22(1):25-31.
3. Li XR, Ji F, Ouyang J, Wu W, Qian LY, Yang KY. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 2006, 32(10):1130-1134. 10.1016/j.ejso.2006.05.012, 16806792.
4. Gomez Del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 2005, 27(6):602-613. 10.1002/bies.20238, 15892119.
5. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81(1):53-62. 10.1016/0092-8674(95)90370-4, 7536630.
6. Rottner K, Hall A, Small JV. Interplay between Rac and Rho in the control of substrate contact dynamics. Curr Biol 1999, 9(12):640-648. 10.1016/S0960-9822(99)80286-3, 10375527.
7. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999, 147(5):1009-1022. 10.1083/jcb.147.5.1009, 2169355, 10579721.
8. Haataja L, Groffen J, Heisterkamp N. Characterization of RAC3, a novel member of the Rho family. J Biol Chem 1997, 272(33):20384-20388. 10.1074/jbc.272.33.20384, 9252344.
9. Chou MM, Blenis J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 1996, 85(4):573-583. 10.1016/S0092-8674(00)81257-X, 8653792.
10. Baugher PJ, Krishnamoorthy L, Price JE, Dharmawardhane SF. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Res 2005, 7(6):R965-974. 10.1186/bcr1329, 1410764, 16280046.
11. Karnoub AE, Worthylake DK, Rossman KL, Pruitt WM, Campbell SL, Sondek J, Der CJ. Molecular basis for Rac1 recognition by guanine nucleotide exchange factors. Nat Struct Biol 2001, 8(12):1037-1041. 10.1038/nsb719, 11685227.
12. Cho YJ, Zhang B, Kaartinen V, Haataja L, de Curtis I, Groffen J, Heisterkamp N. Generation of rac3 null mutant mice: role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia. Mol Cell Biol 2005, 25(13):5777-5785. 10.1128/MCB.25.13.5777-5785.2005, 1157002, 15964830.
13. Leung K, Nagy A, Gonzalez-Gomez I, Groffen J, Heisterkamp N, Kaartinen V. Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions. Cells, tissues, organs 2003, 175(2):72-83. 10.1159/000073751, 14605486.
14. Hwang SL, Chang JH, Cheng TS, Sy WD, Lieu AS, Lin CL, Lee KS, Howng SL, Hong YR. Expression of Rac3 in human brain tumors. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia 2005, 12(5):571-574.
15. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002, 20((5):446-448.
16. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004, 315(3):686-691. 10.1016/j.bbrc.2004.01.108, 14975755.
17. Cominetti MR, Martin AC, Ribeiro JU, Djaafri I, Fauvel-Lafeve F, Crepin M, Selistre-de-Araujo HS. Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions. Biochimie 2009, 91(8):1045-1052. 10.1016/j.biochi.2009.05.012, 19505527.
18. Monnet E, Sizaret P, Arbeille B, Fauvel-Lafeve F. Different role of platelet glycoprotein GP Ia/IIa in platelet contact and activation induced by type I and type III collagens. Thromb Res 2000, 98(5):423-433. 10.1016/S0049-3848(00)00199-7, 10828482.
19. Mekrache M, Legendre P, Kieffer N, Baruch D. Activation of integrin alphaIIbbeta3 expressed in Chinese hamster ovary cells is required for interaction with solid-phase von Willebrand factor. Br J Haematol 2002, 119(4):1024-1032. 10.1046/j.1365-2141.2002.03960.x, 12472584.
20. Garamszegi N, Garamszegi SP, Shehadeh LA, Scully SP. Extracellular matrix-induced gene expression in human breast cancer cells. Mol Cancer Res 2009, 7(3):319-329. 10.1158/1541-7786.MCR-08-0227, 2681181, 19276183.
21. Zohrabian VM, Nandu H, Gulati N, Khitrov G, Zhao C, Mohan A, Demattia J, Braun A, Das K, Murali R, et al. Gene expression profiling of metastatic brain cancer. Oncol Rep 2007, 18(2):321-328.
22. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett 2007, 254(2):157-164. 10.1016/j.canlet.2006.12.036, 17306454.
23. Pille JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 2005, 11(2):267-274. 10.1016/j.ymthe.2004.08.029, 15668138.
24. Mira JP, Benard V, Groffen J, Sanders LC, Knaus UG. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci U S A 2000, 97(1):185-189. 10.1073/pnas.97.1.185, 26637, 10618392.
25. Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005, 24(53):7821-7829. 10.1038/sj.onc.1208909, 16027728.
26. Hajdo-Milasinovic A, Ellenbroek SI, van Es S, van der Vaart B, Collard JG. Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cells. J Cell Sci 2007, 120(Pt 4):555-566.
27. Joyce PL, Cox AD. Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling. Cancer Res 2003, 63(22):7959-7967.
28. Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010, 29(1):223-237. 10.1007/s10555-010-9211-x, 20112053.
29. Pecheur I, Peyruchaud O, Serre CM, Guglielmi J, Voland C, Bourre F, Margue C, Cohen-Solal M, Buffet A, Kieffer N, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 2002, 16(10):1266-1268.
30. Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008, 88(2):489-513. 10.1152/physrev.00021.2007, 18391171.
31. Sheetz MP, Felsenfeld DP, Galbraith CG. Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol 1998, 8(2):51-54.
32. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS 2004, 112(7-8):508-525.
33. Sun B, Qie S, Zhang S, Sun T, Zhao X, Gao S, Ni C, Wang X, Liu Y, Zhang L. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 2008, 39(3):444-451. 10.1016/j.humpath.2007.07.018, 18261629.
34. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997, 88(2):213-222. 10.1016/S0092-8674(00)81842-5, 9008162.
35. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000, 18:621-663. 10.1146/annurev.immunol.18.1.621, 10837071.
36. Ling H, Yang H, Tan SH, Chui WK, Chew EH. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kappaB activation. Br J Pharmacol 2010, 161(8):1763-1777. 10.1111/j.1476-5381.2010.00991.x, 3010581, 20718733.
37. Vayalil PK, Katiyar SK. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate 2004, 59(1):33-42. 10.1002/pros.10352, 14991864.
38. Gupta S, Su H, Bi R, Agrawal S, Gollapudi S. Life and death of lymphocytes: a role in immunesenescence. Immunity & ageing: I & A 2005, 2:12. 10.1186/1742-4933-2-12, 23418627.
39. Kishimoto T. The biology of interleukin-6. Blood 1989, 74(1):1-10.
40. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765. 10.1146/annurev.immunol.19.1.683, 11244051.
41. Yssel H, De Waal MR, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, de Vries JE. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992, 149(7):2378-2384.
42. Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 2003, 48:82-84.
43. Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997, 71(2):257-266. 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D, 9139852.
44. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336(15):1066-1071. 10.1056/NEJM199704103361506, 9091804.
45. Amiri KI, Richmond A. Fine tuning the transcriptional regulation of the CXCL1 chemokine. Prog Nucleic Acid Res Mol Biol 2003, 74:1-36. 3140403, 14510072.
46. Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 2011, 71(15):5296-5306. 10.1158/0008-5472.CAN-11-0156, 3148346, 21653678.
47. Patel S, Vetale S, Teli P, Mistry R, Chiplunkar S. IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2. J Cell Mol Med 2011,
48. Takenawa T, Miki H. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci 2001, 114(Pt 10):1801-1809.